サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1423921

オンコロジー向けAI市場、シェア、規模、動向、産業分析レポート：がんの種類別、コンポーネント別、治療タイプ別、地域別、セグメント別予測、2024年～2032年

AI in oncology Market Share, Size, Trends, Industry Analysis Report, By Component Type (Software Solutions, Hardware), By Cancer Type (Breast Cancer, Lung Cancer), By Treatment Type, By Region, And Segment Forecasts, 2024 - 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 116 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
オンコロジー向けAI市場、シェア、規模、動向、産業分析レポート：がんの種類別、コンポーネント別、治療タイプ別、地域別、セグメント別予測、2024年～2032年
出版日: 2024年01月24日
発行: Polaris Market Research
ページ情報: 英文 116 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界のオンコロジー向けAI市場規模は2032年までに167億2,000万米ドルに達する見込みです。当レポートでは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

がんの罹患率が上昇し、がんの診断、治療、分析のための技術的に高度な製品への需要を牽引しているため、市場は大幅な成長が見込まれています。例えば、国際がん研究機関（IARC）は、2023年に2,070万人以上の新規患者が発生すると予測しています。さらに、AIは早期発見において重要な役割を果たしており、特に効果的なスクリーニングプログラムを通じて死亡率の減少に貢献しています。

AIは、ディープラーニングや高性能コンピューティングの進歩と相まって、マルチオミクス解析によって生成された膨大なデータセットを活用することで、オンコロジーの分野に革命をもたらしています。オンコロジーへのAIの統合は、がんの検出、スクリーニング、診断、分類など、がん管理のさまざまな段階に対する新たなアプローチを包含しています。AIは、がんゲノミクスの特徴づけ、腫瘍微小環境の分析、予後・予測バイオマーカーの評価、フォローアップケアや創薬の戦略策定に役立っています。このようなAIの包括的な応用は、がん研究と治療の精度と効率を高めています。

特に正確性、安全性、自動化という点で、技術の急速な進歩が予測可能な将来の市場成長を促進するものと思われます。AIは、新たな変革技術として、オンコロジー分野の検診率を大幅に向上させる上で重要な役割を果たしています。その結果、公的機関も民間企業も、AIベースの腫瘍スクリーニング製品の進歩を目指した研究開発（R&D）イニシアチブに多額の資金と投資を行うことに注力しています。

例えば、2023年3月、アルテラは9,000万米ドルの資金を確保しました。この資金はArteraAI Prostate Testの発売と販売に充てられるもので、限局性前立腺がんの治療結果を予測するために初めて開発された検査として重要なマイルストーンとなります。これは、スクリーニングの効率と治療の意思決定を強化する可能性を持つ、オンコロジーにおける革新的なAI主導型ソリューションに対する認識と支持の高まりを示すものです。

業界の主なプレーヤーは、がんの早期診断の促進、需要の増加への対応、研究開発パイプラインの推進を目的とした革新的な製品の開発に主眼を置いて、戦略的に提携や共同研究に取り組んでいます。例えば、2022年12月、アストラゼネカは肺がんに焦点を当てたAIプロジェクトに着手するため、クリニシンクと協業を開始しました。このプロジェクトの主な目的は、肺がんの早期発見であり、それによってより効果的な治療戦略の策定に貢献します。

オンコロジー向けAI市場レポートハイライト

ソフトウェアソリューション分野が最大のシェアを占めましたが、これは主に臨床転帰を改善するためのAIベースのサービスの採用によるものです。

脳腫瘍症例の増加と膨大なアンメットメディカルニーズにより、脳腫瘍分野が最も速い速度で成長する見込み

北米は医療インフラが充実しており、医療ソリューションを提供するAIプレーヤーも存在することから、同市場は北米が支配的でした。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のオンコロジー向けAI市場洞察

  • オンコロジー向けAI市場-治療タイプのスナップショット
  • オンコロジー向けAI市場力学
    • 促進要因と機会
      • がんの罹患率の増加
      • 治療の最適化
    • 抑制要因と課題
      • データのプライバシーとセキュリティに関する懸念
  • PESTEL分析
  • オンコロジー向けAI市場、治療タイプの動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界のオンコロジー向けAI市場、がんの種類別

  • 主な調査結果
  • イントロダクション
  • 乳がん
  • 肺がん
  • 前立腺がん
  • 大腸がん
  • 脳腫瘍
  • その他

第6章 世界のオンコロジー向けAI市場、コンポーネント別

  • 主な調査結果
  • イントロダクション
  • ソフトウェアソリューション
  • ハードウェア
  • サービス

第7章 世界のオンコロジー向けAI市場、治療タイプ別

  • 主な調査結果
  • イントロダクション
  • 化学療法
  • 放射線療法
  • 免疫療法
  • その他

第8章世界のオンコロジー向けAI市場、地域別

  • 主な調査結果
  • イントロダクション
    • オンコロジー向けAI市場評価、地域別、2019～2032年
  • オンコロジー向けAI市場-北米
    • 北米：オンコロジー向けAI市場、がんの種類別、2019～2032年
    • 北米：オンコロジー向けAI市場、治療タイプ別、2019～2032年
    • 北米：オンコロジー向けAI市場、コンポーネント別、2019～2032年
    • オンコロジー向けAI市場-米国
    • オンコロジー向けAI市場-カナダ
  • オンコロジー向けAI市場-欧州
    • 欧州：オンコロジー向けAI市場、がんの種類別、2019～2032年
    • 欧州：オンコロジー向けAI市場、治療タイプ別、2019～2032年
    • 欧州：オンコロジー向けAI市場、コンポーネント別、2019～2032年
    • オンコロジー向けAI市場-英国
    • オンコロジー向けAI市場-フランス
    • オンコロジー向けAI市場-ドイツ
    • オンコロジー向けAI市場-イタリア
    • オンコロジー向けAI市場-スペイン
    • オンコロジー向けAI市場-オランダ
    • オンコロジー向けAI市場-ロシア
  • オンコロジー向けAI市場-アジア太平洋
    • アジア太平洋：オンコロジー向けAI市場、がんの種類別、2019～2032年
    • アジア太平洋：オンコロジー向けAI市場、治療タイプ別、2019～2032年
    • アジア太平洋：オンコロジー向けAI市場、コンポーネント別、2019～2032年
    • オンコロジー向けAI市場-中国
    • オンコロジー向けAI市場-インド
    • オンコロジー向けAI市場-マレーシア
    • オンコロジー向けAI市場-日本
    • オンコロジー向けAI市場-インドネシア
    • オンコロジー向けAI市場-韓国
  • オンコロジー向けAI市場-中東およびアフリカ
    • 中東およびアフリカ：オンコロジー向けAI市場、がんの種類別、2019～2032年
    • 中東およびアフリカ：オンコロジー向けAI市場、治療タイプ別、2019～2032年
    • 中東およびアフリカ：オンコロジー向けAI市場、コンポーネント別、2019～2032年
    • オンコロジー向けAI市場-サウジアラビア
    • オンコロジー向けAI市場-UAE
    • オンコロジー向けAI市場-イスラエル
    • オンコロジー向けAI市場-南アフリカ
  • オンコロジー向けAI市場-ラテンアメリカ
    • ラテンアメリカ：オンコロジー向けAI市場、がんの種類別、2019～2032年
    • ラテンアメリカ：オンコロジー向けAI市場、治療タイプ別、2019～2032年
    • ラテンアメリカ：オンコロジー向けAI市場、コンポーネント別、2019～2032年
    • オンコロジー向けAI市場-メキシコ
    • オンコロジー向けAI市場-ブラジル
    • オンコロジー向けAI市場-アルゼンチン

第9章 競合情勢

  • 拡張と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Azra AI
  • IBM
  • Siemens Healthcare GmbH
  • Intel Corporation
  • GE HealthCare
  • NVIDIA Corporation
  • Digital Diagnostics Inc.
  • ConcertAI
  • Median Technologies
  • PathAI
図表

List of Tables

  • Table 1 Global AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 2 Global AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 3 Global AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 4 AI in Oncology Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 6 North America: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 7 North America: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 8 U.S.: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 9 U.S.: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 10 U.S.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 11 Canada: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 12 Canada: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 13 Canada: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 14 Europe: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 15 Europe: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 16 Europe: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 17 UK: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 18 UK: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 19 UK: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 20 France: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 21 France: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 22 France: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 23 Germany: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 24 Germany: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 25 Germany: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 26 Italy: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 27 Italy: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 28 Italy: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 29 Spain: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 30 Spain: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 31 Spain: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 32 Netherlands: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 33 Netherlands: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 34 Netherlands: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 35 Russia: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 36 Russia: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 37 Russia: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 41 China: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 42 China: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 43 China: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 44 India: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 45 India: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 46 India: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 47 Malaysia: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 48 Malaysia: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 49 Malaysia: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 50 Japan: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 51 Japan: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 52 Japan: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 53 Indonesia: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 54 Indonesia: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 55 Indonesia: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 56 South Korea: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 57 South Korea: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 58 South Korea: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 65 UAE: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 66 UAE: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 67 UAE: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 68 Israel: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 69 Israel: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 70 Israel: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 71 South Africa: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 72 South Africa: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 73 South Africa: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 74 Latin America: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 75 Latin America: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 76 Latin America: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 77 Mexico: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 78 Mexico: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 79 Mexico: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 80 Brazil: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 81 Brazil: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 82 Brazil: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 83 Argentina: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 84 Argentina: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 85 Argentina: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global AI in Oncology Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Component
  • Figure 7. Global AI in Oncology Market, by Component, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Cancer Type
  • Figure 9. Global AI in Oncology Market, by Cancer Type, 2022 & 2032 (USD Billion)
  • Figure 10. Market by Treatment Type
  • Figure 11. Global AI in Oncology Market, by Treatment Type, 2022 & 2032 (USD Billion)
  • Figure 12. AI in Oncology Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - AI in Oncology Market
目次
Product Code: PM4153

The global AI in oncology market size is expected to reach USD 16.72 billion by 2032, according to a new study by Polaris Market Research. The report "AI in oncology Market Share, Size, Trends, Industry Analysis Report, By Component Type (Software Solutions, Hardware), By Cancer Type (Breast Cancer, Lung Cancer), By Treatment Type, By Region, And Segment Forecasts, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The market is poised for substantial growth due to the rising incidence of cancer, driving the demand for technologically advanced products for cancer diagnosis, treatment, and analysis. For instance, the International Agency for Research on Cancer (IARC) estimates over 20.7 million new cases, in 2023. Furthermore, AI plays a crucial role in early detection, contributing to mortality reduction, particularly through effective screening programs.

AI is revolutionizing the field of oncology by leveraging vast datasets generated through multi-omics analyses, coupled with advancements in deep learning and high-performance computing. This integration of AI into oncology encompasses novel approaches for various stages of cancer management, including detection, screening, diagnosis, and classification. AI is instrumental in characterizing cancer genomics, analyzing the tumor microenvironment, assessing prognostic and predictive biomarkers, and formulating strategies for follow-up care and drug discovery. This comprehensive application of AI is enhancing the precision and efficiency of cancer research and treatment.

The rapid progression of technology, particularly in terms of accuracy, safety, and automation, is poised to drive market growth in the foreseeable future. AI, as an emerging and transformative technology, plays a crucial role in significantly increasing screening rates in the field of oncology. Consequently, both public and private organizations are directing their focus towards substantial funding and investment in research and development (R&D) initiatives aimed at advancing AI-based oncology screening products.

For instance, in March 2023, Artera secured funding of nearly, USD 90 million. This funding is earmarked for the launch and distribution of the ArteraAI Prostate Test, marking a significant milestone as the first developed test designed to predict therapy outcomes in localized prostate cancer. This illustrates the growing recognition and support for innovative AI-driven solutions in oncology, with the potential to enhance screening efficiency and therapeutic decision-making.

Key industry players are strategically engaging in collaborations and partnerships, with a primary emphasis on the development of innovative products aimed at facilitating early cancer diagnosis, addressing increasing demand, and advancing research and development pipelines. For instance, in December 2022, AstraZeneca initiated a collaboration with Clinithink to embark on an AI project focused on lung cancer. The primary objective of this project is the early detection of lung cancer, thereby contributing to the formulation of more effective treatment strategies.

AI in Oncology Market Report Highlights

Software solutions segment held the largest share, primarily due to adoption of AI based services for better clinical outcomes

Brain tumor segment expected to grow at the fastest rate, owing to rising cases of brain tumors and huge unmet medical needs

North America dominated the market, as the region has better healthcare infrastructure, coupled with AI players offering healthcare solutions

The global players include Azra AI, IBM, Siemens Healthcare, Intel, GE HealthCare, NVIDIA, Digital Diagnostics, ConcertAI, Median Technologies, and PathAI

Polaris Market Research has segmented the AI in oncology market report based on component, cancer type, treatment type, and region:

AI in Oncology, Component Outlook (Revenue - USD Billion, 2019 - 2032)

  • Software Solutions
  • Hardware
  • Services

AI in Oncology, Cancer Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Brain Tumor
  • Others

AI in Oncology, Treatment Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Chemotherapy
  • Radiotherapy
  • Immunotherapy
  • Others

AI in Oncology, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global AI in Oncology Market Insights

  • 4.1. AI in Oncology Market - Treatment Type Snapshot
  • 4.2. AI in Oncology Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing prevalence of cancer
      • 4.2.1.2. Treatment Optimization
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Data Privacy and Security Concerns
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. AI in Oncology Market Treatment Type Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global AI in Oncology Market, by Cancer Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • 5.3. Breast Cancer
    • 5.3.1. Global AI in Oncology Market, by Breast Cancer, by Region, 2019-2032 (USD Billion)
  • 5.4. Lung Cancer
    • 5.4.1. Global AI in Oncology Market, by Lung Cancer, by Region, 2019-2032 (USD Billion)
  • 5.5. Prostate Cancer
    • 5.5.1. Global AI in Oncology Market, by Prostate Cancer, by Region, 2019-2032 (USD Billion)
  • 5.6. Colorectal Cancer
    • 5.6.1. Global AI in Oncology Market, by Colorectal Cancer, by Region, 2019-2032 (USD Billion)
  • 5.7. Brain Tumor
    • 5.7.1. Global AI in Oncology Market, by Brain Tumor, by Region, 2019-2032 (USD Billion)
  • 5.8. Others
    • 5.8.1. Global AI in Oncology Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global AI in Oncology Market, by Component

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • 6.3. Software Solutions
    • 6.3.1. Global AI in Oncology Market, by Software Solutions, by Region, 2019-2032 (USD Billion)
  • 6.4. Hardware
    • 6.4.1. Global AI in Oncology Market, by Hardware, by Region, 2019-2032 (USD Billion)
  • 6.5. Services
    • 6.5.1. Global AI in Oncology Market, by Services, by Region, 2019-2032 (USD Billion)

7. Global AI in Oncology Market, by Treatment Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • 7.3. Chemotherapy
    • 7.3.1. Global AI in Oncology Market, by Chemotherapy, By Region, 2019-2032 (USD Billion)
  • 7.4. Radiotherapy
    • 7.4.1. Global AI in Oncology Market, by Radiotherapy, By Region, 2019-2032 (USD Billion)
  • 7.5. Immunotherapy
    • 7.5.1. Global AI in Oncology Market, by Immunotherapy, By Region, 2019-2032 (USD Billion)
  • 7.6. Others
    • 7.6.1. Global AI in Oncology Market, by Others, By Region, 2019-2032 (USD Billion)

8. Global AI in Oncology Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. AI in Oncology Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. AI in Oncology Market - North America
    • 8.3.1. North America: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.3.2. North America: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
    • 8.3.3. North America: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.3.4. AI in Oncology Market - U.S.
      • 8.3.4.1. U.S.: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.3.5. AI in Oncology Market - Canada
      • 8.3.5.1. Canada: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • 8.4. AI in Oncology Market - Europe
    • 8.4.1. Europe: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
    • 8.4.3. Europe: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.4.4. AI in Oncology Market - UK
      • 8.4.4.1. UK: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.4.5. AI in Oncology Market - France
      • 8.4.5.1. France: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.4.5.3. France: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.4.6. AI in Oncology Market - Germany
      • 8.4.6.1. Germany: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.4.7. AI in Oncology Market - Italy
      • 8.4.7.1. Italy: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.4.8. AI in Oncology Market - Spain
      • 8.4.8.1. Spain: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.4.9. AI in Oncology Market - Netherlands
      • 8.4.9.1. Netherlands: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.4.10. AI in Oncology Market - Russia
      • 8.4.10.1. Russia: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • 8.5. AI in Oncology Market - Asia Pacific
    • 8.5.1. Asia Pacific: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.5.4. AI in Oncology Market - China
      • 8.5.4.1. China: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.5.4.3. China: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.5.5. AI in Oncology Market - India
      • 8.5.5.1. India: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.5.5.3. India: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.5.6. AI in Oncology Market - Malaysia
      • 8.5.6.1. Malaysia: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.5.7. AI in Oncology Market - Japan
      • 8.5.7.1. Japan: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.5.8. AI in Oncology Market - Indonesia
      • 8.5.8.1. Indonesia: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.5.9. AI in Oncology Market - South Korea
      • 8.5.9.1. South Korea: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • 8.6. AI in Oncology Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.6.4. AI in Oncology Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.6.5. AI in Oncology Market - UAE
      • 8.6.5.1. UAE: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.6.6. AI in Oncology Market - Israel
      • 8.6.6.1. Israel: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.6.7. AI in Oncology Market - South Africa
      • 8.6.7.1. South Africa: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • 8.7. AI in Oncology Market - Latin America
    • 8.7.1. Latin America: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.7.4. AI in Oncology Market - Mexico
      • 8.7.4.1. Mexico: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.7.5. AI in Oncology Market - Brazil
      • 8.7.5.1. Brazil: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.7.6. AI in Oncology Market - Argentina
      • 8.7.6.1. Argentina: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: AI in Oncology Market, by Component, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Azra AI
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. IBM
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Siemens Healthcare GmbH
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Intel Corporation
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. GE HealthCare
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. NVIDIA Corporation
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Digital Diagnostics Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. ConcertAI
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Median Technologies
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. PathAI
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development